Abstract
The expression of genes encoding the cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase (FAAH) and the lipolytic activity of cannabinoid agonists were investigated in rat adipose tissue.
RT-PCR studies indicated that the genes encoding CB1 and CB2 receptors and FAAH are not expressed in epididymal adipocytes. In functional studies, the non-selective cannabinoid receptor agonist WIN 55,212-2 concentration-dependently (0.01–30 µM) induced glycerol release above baseline (E max 96.1±6.2% of isoprenaline-induced lipolytic response). The selective CB2 agonist JWH-015 (0.01–30 µM) had no lipolytic activity while the endocannabinoid 2-arachidonoylglycerol and the stable anandamide derivative, R(+)-methanandamide had, only a weak lipolytic effect at the highest concentrations employed (10 and 30 µM). The concentration/response relationship for WIN 55,212-2-mediated lipolytic activity, mimicked by the S(−)-enantiomer WIN 55,212-3, was shifted significantly to the right by the CB1 antagonist AM 251 only at 10 µM, but was not modified by the β-adrenoceptor antagonist propranolol (1 µM). The protein kinase inhibitor H-89, but not the two adenylyl cyclase inhibitors (±)N 6-R-phenylisopropyladenosine (R-PIA, 1 µM, a selective A1 adenosine receptor agonist) or SQ 22,536 (50 µM) significantly reduced the glycerol efflux induced by WIN 55,212-2.
Our data suggest that the cannabinoid drug WIN 55,212-2 may exert lipolytic activity in male rat adipocytes via an intracellular mechanism, not activated by CB1 or CB2 receptor stimulation, significantly reversed by H-89 but not clearly linked to stimulation of adenylyl cyclase.
Similar content being viewed by others
References
Ameri A, Simmet T (2000) Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn-Schmiedeberg’s Arch Pharmacol 361:256–272
Breivogel C, Griffin G, Di Marzo V, Martin B (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163
Chatzipanteli K, Rudolph S, Axelrod L (1992) Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes 41:927–935
Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P (2001) Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20:7033–7040
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Coruzzi G, Adami M, Coppelli G, Frati P, Soldani G (1999) Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat. Naunyn-Schmiedeberg’s Arch Pharmacol 360:715–718
Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand J, Le Fur G, Mukenge S, Ferla G (1998) In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125:1393–1395
Cushman S (1970) Structure-function relationships in the adipose cell. Ultrastructure of the isolated adipose cell. J Cell Biol 46:326–341
Das S, Paria B, Chakraborty I, Dey S (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332–4336
Di Marzo V (1998) ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392:153–175
Di Marzo V (1999) Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. Life Sci 65:645–655
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686–691
Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822–825
Egertova M, Giang D, Cravatt B, Elphick M (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc R Soc Lond B Biol Sci 265:2081–2085
Fleischmann B, Murray R, Kotlikoff M (1994) Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc Natl Acad Sci USA 91:11914–11918
Frühbeck G, Gòmez-Ambrosi J (2001) Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal 13:827–833
Garcia-Barrado M, Sancho C, Iglesias-Osma M, Moratinos J (2001) Effects of verapamil and elgodipine on isoprenaline-induced metabolic responses in rabbits. Eur J Pharmacol 415:105–115
Gebremedhin D, Lange A, Campbell W, Hillard C, Harder D (1999) Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol 276:H2085–H2093
Girouard H, Savard R (1998) The lack of bimodality in the effects of endogenous and exogenous prostaglandins on fat cell lipolysis in rats. Prostaglandins Other Lipid Mediat 56:43–45
Giuffrida A, Beltramo M, Piomelli D (2001) Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther 298:7–14
Gowri M, Reaven G, Azhar S (1999) Effect of masoprocol on glucose transport and lipolysis by isolated rat adipocytes. Metabolism 48:411–414
Guzman M, Sanchez C (1999) Effects of cannabinoids on energy metabolism. Life Sci 65:657–664
Hàjos N, Freund TF (2002) Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43:503–510
Hàjos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF (2001) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239–3249
Haslam RJ, Davidson MM, Desjardins JV (1978) Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 176:83–95
Holland M, John Challiss R, Standen N, Boyle J (1999) Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle. Br J Pharmacol 128:597–604
Holm C, Osterlund T, Laurell H, Contreras J (2000) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 20:365–393
Howlett AC, Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108:53–70
Izzo AA, Mascolo N, Capasso R, Germano MP, De Pasquale R, Capasso F (1999) Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn-Schmiedeberg’s Arch Pharmacol 360:221–223
Kathmann M, Weber B, Schlicker E (2001) Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Naunyn- Schmiedeberg’s Arch Pharmacol 363:50–56
Kreuz D, Axelrod J (1973) Δ9-Tetrahydrocannabinol: localization in body fat. Science 179:391–393
Kunos G, Jàrai Z, Bàtkai S, Goparaju SK, Ishac EJN, Liu J, Wang L, Wagner JA (2000) Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 108:159–168
Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J Med Chem 42:769–76
Liang HX, Belardinelli L, Ozeck MJ, Shryock JC (2002) Tonic activity of the rat adipocyte A1-adenosine receptor. Br J Pharmacol 135:1457–1466
Maccarrone M, Fiorucci L, Erba F, Bari M, Finazzi-Agro A, Ascoli F (2000) Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors. FEBS Lett 468:176–180
Maier R, Maitre L (1975) Steroidogenic and lipolytic effects of cannabinols in the rat and the rabbit. Biochem Pharmacol 24:1695–1699
Malinowska B, Kwolek G, Gothert M (2001) Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn-Schmiedeberg’s Arch Pharmacol 364:562–569
Mater M, Thelen A, Jump D (1999) Arachidonic acid and PGE2 regulation of hepatic lipogenic gene expression. J Lipid Res 40:1045–1052
Matsuda L, Lolait S, Brownstein M, Young A, Bonner T (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564
Munro S, Thomas K, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65
Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn-Schmiedeberg’s Arch Pharmacol 361:19–24
Niederhoffer N, Szabo B (1999) Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br J Pharmacol 126:457–466
Nogueron M, Porgilsson B, Schneider W, Stucky C, Hillard C (2001) Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. J Neurochem 79:371–381
Pertwee R (1999) Pharmacology of cannabinoid receptor ligands. Curr Med Chem 6:635–664
Pertwee R, Fernando S (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118:2053–2058
Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F (2000) The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218–224
Ramirez-Ponce M, Acosta J, Bellido J (1990) Electrical activity in white adipose tissue of rat. Rev Esp Fisiol 46:133–138
Rawitch A, Rohrer R, Vardaris R (1979) Δ9-Tetrahydrocannabinol uptake by adipose tissue: preferential accumulation in gonadal fat organs. Gen Pharmacol 10:525–529
Rice W, Shannon J, Burton F, Fiedeldey D (1997) Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: regulation by hydrocortisone. Eur J Pharmacol 327:227–232
Rodbell M (1964) Metabolism of isolated fat cells. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375–380
Sanchez C, Velasco G, Guzman M (1997) Δ9-Tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res 767:64–71
Sanchez C, Galve-Roperh I, Rueda D, Guzman M (1998) Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Δ9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol 54:834–843
Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142:278–287
Schulte G, Fredholm BB (2002) Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists. Cell Signal 14:109–113
Strosberg AD (1997) Structure and function of the beta 3-adrenergic receptor. Annu Rev Pharmacol Toxicol 37:421–50
Ueda N, Puffenbarger R, Yamamoto S, Deutsch D (2000) The fatty acid amide hydrolase (FAAH). Chem Phys Lipids 108:107–121
Volkow N, Tancredi L, Grant C, Gillespie H, Valentine A, Mullani N, Wang G, Hollister L (1995) Brain glucose metabolism in violent psychiatric patients: a preliminary study. Psychiatry Res 61:243–253
Wallmichrath I, Szabo B (2002) Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata. Naunyn-Schmiedeberg’s Arch Pharmacol 365:326–334
Wieland O (1957) Eine enzymatische Methode zur Bestimmung von Glycerin. Biochem Z 329:313–319
Willinsky M, Webster C, Herring B (1974) Effects of Δ1-tetrahydrocannabinol on Sidman discriminated avoidance behavior in rats. Act Nerv Super (Praha) 16:34–38
Xue B, Greenberg A, Kraemer F, Zemel M (2001) Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J 15:2527–2529
Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452–457
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nieri, P., Greco, R., Adinolfi, B. et al. CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes. Naunyn-Schmiedeberg's Arch Pharmacol 368, 352–359 (2003). https://doi.org/10.1007/s00210-003-0831-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-003-0831-3